Abuse-Deterrent 12 HR oxycodone 13.5 MG Extended Release Oral Capsule [Xtampza]
RxNorm concept 1791560, branded drug (sbd). Prescribable name: Xtampza ER 13.5 MG 12HR Extended Release Oral Capsule.
- RxCUI
- 1791560
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1791560 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Abuse-Deterrent 12 HR oxyCODONE 13.5 MG Extended Release Oral Capsule [Xtampza]; Xtampza ER 13.5 MG (equivalent to 15 MG oxyCODONE HCl) 12 HR Extended Release Oral Capsule; Xtampza ER 13.5 MG (equivalent to 15 MG oxycodone HCl) 12 HR Extended Release Oral Capsule; Xtampza ER 13.5 MG 12 HR Extended Release Oral Capsule
Related concepts
- oxycodone 13.5 MG (SCDC, consists of)
- oxycodone 13.5 MG [Xtampza] (SBDC, consists of)
- Extended Release Oral Capsule (DF, has dose form)
- Xtampza (BN, has ingredient)
- Abuse-Deterrent 12 HR oxycodone 13.5 MG Extended Release Oral Capsule (SCD, tradename of)
Linked data
NDCs
- 24510011510
- 24510011520
- 55700055730
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1791560 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1791560 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1791560. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.